B.Riley/FBR Upgrades Arrowhead Research (ARWR) to Buy

Go back to B.Riley/FBR Upgrades Arrowhead Research (ARWR) to Buy

Arrowhead Pharmaceuticals Corp (ARWR) Adds to Gains; Up 57%

September 6, 2018 10:44 AM EDT

Arrowhead Pharmaceuticals Corp (NASDAQ: ARWR) adds to early gains following data. Shares are now up 57%.

... More